Folate supplementation in people with sickle cell disease

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 2, 2016, Pages

  Dixit, Ruchita ^a   Nettem, Sowmya ^a   Madan, Simerjit S ^a   Soe, Htoo Htoo Kyaw ^a   Abas, Adinegara B L ^a   Vance, Leah D ^b   Stover, Patrick J ^c  

^a MELAKA MANIPAL MEDICAL COLLEGE   (India)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Melaka ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM LACTATE; COBALAMIN; FOLIC ACID; HEMOGLOBIN; HOMOCYSTEINE; PLACEBO; ANTIANEMIC AGENT;

ADVERSE DRUG REACTION; BODY HEIGHT; BODY WEIGHT; CHILD GROWTH; CLUSTER ANALYSIS; COBALAMIN DEFICIENCY; DACTYLITIS; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FOLIC ACID BLOOD LEVEL; GROWTH RATE; HEMOGLOBIN DETERMINATION; HUMAN; INFECTION; INTENTION TO TREAT ANALYSIS; MENTAL DISEASE; META ANALYSIS; POTENTIAL DIFFERENCE; PRIAPISM; PRIORITY JOURNAL; QUALITY OF LIFE; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SICKLE CELL ANEMIA; SIDE EFFECT; SYSTEMATIC REVIEW; VITAMIN D DEFICIENCY; ANEMIA, SICKLE CELL; BLOOD; CHILD; GROWTH; MEAN CORPUSCULAR VOLUME;

ANEMIA, SICKLE CELL; CHILD; ERYTHROCYTE INDICES; FOLIC ACID; GROWTH; HEMATINICS; HUMANS;

EID: 84970028910     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011130.pub2     Document Type: Review

References (47)

1. Rabb LM, Grandison Y, Mason K, Hayes RJ, Serjeant B, Serjeant GR. A trial of folate supplementation in children with homozygous sickle cell disease. British Journal of Haematology 1983;54(4):589-94. [CENTRAL: 31620; CRS: 5500100000000176; PUBMED: 6347243]
2. Cox SE, Makani J, Walter G, Mtunguja S, Kamala BA, Ellins E, et al. Ready-to-use supplementary food supplements improve endothelial function, hemoglobin and growth in Tanzanian children with sickle cell anaemia: the vascular function intervention study (V-FIT), a random order crossover trial [abstract]. Proceedings of the 56th ASH Annual Meeting and Exposition; 2014 Dec 6-9; San Francisco, California 2014;89:Abstract no: 4087. [CENTRAL: 1017322; CRS: 5500131000000279]
3. Marealle A, Makani J, Kirkham F, Prentice A, Cox S. Amino acids in Tanzanian children with sickle cell disease: Baseline results of the vascular function intervention trial (VFIT) [abstract]. FASEB Journal 2015;29(1 Suppl Meeting Abstracts). [CENTRAL: 1080547; CRS: 5500050000000273; EMBASE: 71863886]
4. Hendrickse RG, Barnes PM. Sickle cell anaemia: report of a therapeutic trial. West African Medical Journal 1966;15(2):55-64. [CENTRAL: 477152; CRS: 5500100000002593]
5. Liu YK. Folic acid deficiency in sickle cell anemia. Scandanavian Journal of Haematology 1975;14(1):71-9.
6. Mojtahedzadeh F, Kosaryan M, Mahdavi MR, Akbari J. The effect of folic acid supplementation in beta-thalassemia major: a randomized placebo-controlled clinical trial. Archives of Iranian Medicine 2006;9(3):266-8. [CENTRAL: 566691; CRS: 5500100000002852; EMBASE: 2006356607; PUBMED: 16859064]
7. Kim-Shapiro DB, Dixon N. Study of Beet Juice for Patients With Sickle Cell Anemia (NCT02162225). https://www.clinicaltrials.gov/ct2/show/NCT02162225 (accessed 03 September 2015).
8. Al-Yassin A, Osei A, Rees D. Folic acid supplementation in children with sickle cell disease. Archives of Disease in Childhood 2012;97:A91-92.
9. Aliyu ZY, Tumblin AR, Kato GJ. Current therapy of sickle cell disease. Haematologica 2006;91(1):7-10.
10. Bailey LB. Folate and vitamin B12 recommended intakes and status in the United States. Nutrition Reviews 2004;62(6):14-20.
11. Bailey LB, Caudill MA. Folate. In: Erdman Jr JW, MacDonald IA, Zeisel SH editor(s). Present Knowledge in Nutrition. 10th Edition. Washington, DC: Wiley-Blackwell, 2012:321-42.
12. Blencowe H, Cousens S, Modell B, Lawn J. Folic acid to reduce neonatal mortality from neural tube disorders. International Journal of Epidemiology 2010;39(1):110-21.
13. Carmel R. Folic Acid. In: Shils M, Shike M, Ross A, Caballero B, Cousins R editor(s). Modern Nutrition in Health and Disease. 10th Edition. Lippincott Williams & Wilkins, 2005:470-81.
14. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta analysis of randomized trials. BMJ 1998;316(7135):894-8.
15. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Archives of Internal Medicine 2010;170(18):1622-31.
16. Deeks J, Higgins J, Altman D. Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
17. Dhar M, Bellevue R, Carmel R. Pernicious anemia with neuropsychiatric dysfunction in a patient with sickle cell anemia treated with folate supplementation. New England Journal of Medicine 2003;348(22):2204-7.
18. Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007;369(9557):208-16.
19. Falletta JM, Woods GM, Verter JI, Buchanan GR, Pegelow CH, Iyer RV, et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II. Journal of Pediatrics 1995;127(5):685-90.
20. Galadanci N, Wudil BJ, Balogun TM, Ogunrinde GO, Akinsulie A, Hasan-Hanga F, Mohammed AS, Kehinde MO, Olaniyi JA, Diaku-Akinwumi IN, Brown BJ, Adeleke S, Nnodu OE, Emodi I, Ahmed S, Osegbue AO, Akinola N, Opara HI, Adegoke SA, Aneke J, Adekile AD. Current sickle cell disease management practices in Nigeria [Current sickle cell disease management practices in Nigeria]. International health 2014 Mar;6(1):23-8.
21. Green R. Indicators for assessing folate and vitamin B-12 status and for monitoring the efficacy of intervention strategies. American Journal of Clinical Nutrition 2011 Aug;94(2):666S-72S.
22. Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa: a neglected cause of early childhood mortality. American Journal of Preventive Medicine 2011;41(6 Suppl 4):398-405.
23. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
24. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
25. Huo Y, Li J, Qin X, Huang Y, Wang X, Gottesman RF, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 2015;313(13):1325-35.
26. Ingram VM. Gene mutations in human haemoglobin: the chemical difference between normal and sickle haemoglobin. Nature 1957;180:326-8.
27. Kim YI. Folate: a magic bullet or a double edged sword for colorectal cancer prevention?. Gut 2006;55(10):1387-9.
28. Peter A, Lane S. Sickle Cell Disease. Pediatric Hematology 1996;43(3):639-64.
29. Lee M, Hong KS, Chang SC, Saver JL. Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: a meta-analysis. Stroke 2010;41(6):1205-12.
30. Ndefo UA, Maxwell AE, Nguyen H, Chiobi TL. Pharmacological management of sickle cell disease. Pharmacy and Therapeutics 2008;33(4):238-43.
31. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia: a molecular disease. Science 1949;110:543-8.
32. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 2010;376(9757):2018-31.
33. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
34. Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Present Knowledge in Nutrition 2006;367(9505):133-43.
35. Schnog JB, Duits AJ, Muskiet FAJ, ten Cate H, Rojer RA, Brandjes DPM. Sickle cell disease; a general overview. Netherlands Journal of Medicine 2004;62(10):364-71.
36. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New England Journal of Medicine 1995;332(5):286-91.
37. Serjeant GR. Sickle-cell disease. Lancet 1997;350(9079):725-30.
38. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. 10th Edition. Washington, DC: National Academy Press, 1998.
39. Stott DJ, MacIntosh G, Lowe GD, Rumley A, McMahon AD, Langhorne P, et al. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. American Journal of Clinical Nutrition 2005;82(6):1320-6.
40. Stuart MJ, Nagel RL. Sickle cell disease. Lancet 2004;364(9442):1343-60.
41. Taylor MJ, Carney SM, Geddes J, Goodwin G. Folate for depressive disorders. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD003390]
42. Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. Journal of Nutrition 2006;136(1):189-94.
43. Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50, 000 individuals. Lancet 2013;381(9871):1029-36.
44. Wolff T, Witkop CT, Miller T, Syed SB. Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Update of the Evidence for the U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/folic-acid-to-prevent-neural-tube-defects-preventive-medication (accessed 03 September 2015).
45. Wong TE, Brandow AM, Lim W, Lottenberg R. Update on the use of hydroxyurea therapy in sickle cell disease. Blood 2014;124(26):3850-7.
46. Yetley EA, Pfeiffer CM, Phinney KW, Fazili Z, Lacher DA, Bailey RL, et al. Biomarkers of folate status in NHANES: a roundtable summary. American Journal of Clinical Nutrition 2011;94(1):303-12.
47. Yeung LF, Cogswell ME, Carriquiry AL, Bailey LB, Pfeiffer CM, Berry RJ. Contributions of enriched cereal-grain products, ready-to-eat cereals, and supplements to folic acid and vitamin B-12 usual intake and folate and vitamin B-12 status in US children:National Health and Nutrition Examination Survey (NHANES), 2003-2006. American Journal of Clinical Nutrition 2011;93(1):172-85.